Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

Patients with the chronic inflammatory bowel disease ulcerative colitis might reduce their risk of a relapse by having their appendix removed, a new stu ...

For anyone with ulcerative colitis (UC), remission is a beautiful ... One mistake many of us make, however, is to deviate from our treatment plan when we’re enjoying a remission period.

In April 2025, Janssen Research & Development, LLC announced a study is to evaluate the efficacy, including clinical ...

Although the appendix is generally believed to be a vestigial organ, there is growing evidence pointing to its possible role in modulating gut immunity and microbial homoeostasis.1,2 These roles have ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients with mild-to-moderate ulcerative colitis who drank 130ml of diluted Montmo ...

A study published in The Lancet suggests that removing the appendix may reduce the risk of relapse in patients with ulcerative colitis. The research shows a significant reduction in relapse rates and ...

The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food ...